<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clonal chromosome and/or <z:hpo ids='HP_0001871'>hematological abnormalities</z:hpo> typically observed in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) have been described with increased frequency after autologous bone marrow transplantation (BMT) for <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We report the case of a woman with <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) allografted with her HLA-identical sibling who, 5 years after the transplant and under immunosuppressive treatment for <z:hpo ids='HP_0011010'>chronic</z:hpo> graft host disease (GVHD), suffered a cytogenetic relapse associated with a 5q- deletion in the host metaphases </plain></SENT>
<SENT sid="2" pm="."><plain>These findings suggest that myelodysplastic changes, possibly related to the chemo-radiotherapy conditioning regimen, may also present after allogeneic BMT </plain></SENT>
</text></document>